 Tiffany Weinkopff
Concepts (142)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leishmaniasis, Cutaneous | 6 | 2025 | 12 | 3.920 |
Why?
| | Leishmania major | 5 | 2025 | 9 | 3.040 |
Why?
| | Macrophages | 6 | 2025 | 360 | 2.120 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2025 | 62 | 1.510 |
Why?
| | Lymphangiogenesis | 3 | 2025 | 5 | 1.460 |
Why?
| | Signal Transduction | 5 | 2025 | 1699 | 1.430 |
Why?
| | Lymphatic Vessels | 3 | 2025 | 44 | 1.360 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2019 | 187 | 1.070 |
Why?
| | Lymphatic System | 1 | 2025 | 13 | 0.950 |
Why?
| | Leishmania braziliensis | 3 | 2015 | 3 | 0.940 |
Why?
| | Leishmania | 2 | 2023 | 4 | 0.930 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 2 | 2021 | 3 | 0.820 |
Why?
| | Antigens, Helminth | 3 | 2014 | 5 | 0.780 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 42 | 0.690 |
Why?
| | Mice | 14 | 2025 | 5877 | 0.680 |
Why?
| | Animals | 18 | 2025 | 13332 | 0.670 |
Why?
| | Endothelial Cells | 5 | 2025 | 281 | 0.660 |
Why?
| | Elephantiasis, Filarial | 3 | 2014 | 3 | 0.610 |
Why?
| | Mice, Inbred C57BL | 8 | 2025 | 1872 | 0.540 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 38 | 0.500 |
Why?
| | Cytokines | 3 | 2014 | 621 | 0.500 |
Why?
| | Wuchereria bancrofti | 1 | 2014 | 1 | 0.440 |
Why?
| | Psychodidae | 1 | 2014 | 2 | 0.430 |
Why?
| | Host-Parasite Interactions | 1 | 2014 | 13 | 0.430 |
Why?
| | Saliva | 1 | 2014 | 56 | 0.420 |
Why?
| | Monocytes | 1 | 2014 | 126 | 0.420 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 10 | 0.400 |
Why?
| | Eukaryotic Initiation Factor-2 | 2 | 2023 | 17 | 0.390 |
Why?
| | Lymph Nodes | 2 | 2025 | 252 | 0.360 |
Why?
| | Brugia malayi | 1 | 2011 | 1 | 0.360 |
Why?
| | Neutrophil Activation | 2 | 2024 | 12 | 0.330 |
Why?
| | Brugia pahangi | 1 | 2009 | 1 | 0.320 |
Why?
| | Helminth Proteins | 1 | 2009 | 2 | 0.320 |
Why?
| | Endothelium, Vascular | 1 | 2011 | 257 | 0.310 |
Why?
| | Skin | 2 | 2023 | 418 | 0.290 |
Why?
| | Cells, Cultured | 3 | 2019 | 1568 | 0.270 |
Why?
| | Disease Models, Animal | 3 | 2025 | 1467 | 0.270 |
Why?
| | Mice, Knockout | 3 | 2025 | 893 | 0.250 |
Why?
| | Adaptive Immunity | 1 | 2025 | 32 | 0.230 |
Why?
| | Neutrophils | 2 | 2024 | 146 | 0.230 |
Why?
| | Virus Diseases | 1 | 2025 | 47 | 0.220 |
Why?
| | Leukocytes | 1 | 2025 | 59 | 0.220 |
Why?
| | Th1 Cells | 2 | 2015 | 52 | 0.210 |
Why?
| | Host-Pathogen Interactions | 2 | 2024 | 131 | 0.210 |
Why?
| | Gene Expression Profiling | 2 | 2022 | 1101 | 0.210 |
Why?
| | Adipose Tissue | 1 | 2025 | 204 | 0.200 |
Why?
| | Mycobacterium tuberculosis | 1 | 2024 | 249 | 0.190 |
Why?
| | Blood Platelets | 1 | 2025 | 244 | 0.190 |
Why?
| | Inflammation | 2 | 2025 | 641 | 0.190 |
Why?
| | Transcriptome | 2 | 2022 | 363 | 0.190 |
Why?
| | I-kappa B Kinase | 1 | 2021 | 20 | 0.180 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2021 | 6 | 0.170 |
Why?
| | Disease Susceptibility | 1 | 2021 | 96 | 0.170 |
Why?
| | Orthoreovirus, Mammalian | 1 | 2021 | 17 | 0.170 |
Why?
| | Gerbillinae | 2 | 2011 | 9 | 0.170 |
Why?
| | Interferon Type I | 1 | 2021 | 28 | 0.170 |
Why?
| | Reoviridae Infections | 1 | 2021 | 21 | 0.170 |
Why?
| | B-Lymphocytes | 1 | 2021 | 180 | 0.170 |
Why?
| | Viral Nonstructural Proteins | 1 | 2021 | 61 | 0.160 |
Why?
| | Humans | 10 | 2025 | 52114 | 0.160 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2021 | 163 | 0.160 |
Why?
| | Female | 7 | 2025 | 28055 | 0.150 |
Why?
| | Antigens, CD | 1 | 2019 | 215 | 0.140 |
Why?
| | Hypothalamus | 1 | 2018 | 41 | 0.140 |
Why?
| | Vagina | 1 | 2018 | 46 | 0.140 |
Why?
| | Gastrointestinal Tract | 1 | 2018 | 109 | 0.130 |
Why?
| | Parasite Load | 1 | 2016 | 1 | 0.130 |
Why?
| | Mice, Inbred BALB C | 2 | 2015 | 307 | 0.130 |
Why?
| | Dermis | 1 | 2016 | 19 | 0.130 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 193 | 0.120 |
Why?
| | Stress, Psychological | 1 | 2018 | 273 | 0.120 |
Why?
| | Antibodies | 1 | 2016 | 148 | 0.120 |
Why?
| | Hypersensitivity, Delayed | 1 | 2015 | 18 | 0.120 |
Why?
| | NF-kappa B | 2 | 2021 | 329 | 0.120 |
Why?
| | Th17 Cells | 1 | 2015 | 26 | 0.120 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 1000 | 0.110 |
Why?
| | Cell Movement | 1 | 2015 | 273 | 0.110 |
Why?
| | Brazil | 1 | 2014 | 38 | 0.110 |
Why?
| | Interferons | 1 | 2014 | 37 | 0.110 |
Why?
| | Antibodies, Helminth | 2 | 2011 | 3 | 0.100 |
Why?
| | Leukocytes, Mononuclear | 1 | 2014 | 122 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 182 | 0.100 |
Why?
| | Immunoassay | 1 | 2011 | 23 | 0.090 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2011 | 106 | 0.090 |
Why?
| | Rotavirus Infections | 1 | 2010 | 6 | 0.080 |
Why?
| | Rotavirus | 1 | 2010 | 9 | 0.080 |
Why?
| | Phosphorylation | 1 | 2011 | 523 | 0.080 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 40 | 0.080 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 93 | 0.080 |
Why?
| | Flow Cytometry | 1 | 2011 | 397 | 0.080 |
Why?
| | Immunoblotting | 1 | 2009 | 118 | 0.080 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 66 | 0.080 |
Why?
| | Apoptosis | 1 | 2015 | 1117 | 0.080 |
Why?
| | Amino Acid Sequence | 1 | 2009 | 566 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 766 | 0.070 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2009 | 239 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2011 | 1017 | 0.070 |
Why?
| | Proteomics | 1 | 2009 | 325 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2021 | 392 | 0.060 |
Why?
| | Adipocytes | 1 | 2025 | 130 | 0.050 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2024 | 101 | 0.050 |
Why?
| | Interferon-gamma | 1 | 2024 | 172 | 0.050 |
Why?
| | Tuberculosis | 1 | 2024 | 131 | 0.050 |
Why?
| | Organogenesis | 1 | 2021 | 2 | 0.050 |
Why?
| | I-kappa B Proteins | 1 | 2021 | 16 | 0.050 |
Why?
| | Lymphoid Tissue | 1 | 2021 | 21 | 0.050 |
Why?
| | Mitochondria | 1 | 2024 | 421 | 0.040 |
Why?
| | Lung | 1 | 2024 | 488 | 0.040 |
Why?
| | Homeostasis | 1 | 2021 | 205 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 231 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2021 | 361 | 0.040 |
Why?
| | Cell Line | 1 | 2021 | 1018 | 0.040 |
Why?
| | Fibroblasts | 1 | 2021 | 358 | 0.040 |
Why?
| | Paraventricular Hypothalamic Nucleus | 1 | 2018 | 7 | 0.040 |
Why?
| | Intestinal Absorption | 1 | 2018 | 46 | 0.040 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2018 | 28 | 0.040 |
Why?
| | Male | 3 | 2025 | 26652 | 0.030 |
Why?
| | Cesarean Section | 1 | 2018 | 183 | 0.030 |
Why?
| | Obesity | 1 | 2025 | 1183 | 0.030 |
Why?
| | Body Weight | 1 | 2018 | 526 | 0.030 |
Why?
| | Gene Expression | 1 | 2018 | 618 | 0.030 |
Why?
| | Chemokine CCL21 | 1 | 2015 | 4 | 0.030 |
Why?
| | Receptors, CCR7 | 1 | 2015 | 5 | 0.030 |
Why?
| | Antigens | 1 | 2015 | 41 | 0.030 |
Why?
| | L-Selectin | 1 | 2015 | 6 | 0.030 |
Why?
| | Leukocyte Elastase | 1 | 2015 | 6 | 0.030 |
Why?
| | Phenotype | 1 | 2018 | 794 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2015 | 24 | 0.030 |
Why?
| | Superoxides | 1 | 2015 | 46 | 0.030 |
Why?
| | Child, Preschool | 2 | 2011 | 4001 | 0.020 |
Why?
| | Diethylcarbamazine | 1 | 2011 | 1 | 0.020 |
Why?
| | Haiti | 1 | 2011 | 4 | 0.020 |
Why?
| | Ivermectin | 1 | 2011 | 10 | 0.020 |
Why?
| | Anthelmintics | 1 | 2011 | 12 | 0.020 |
Why?
| | Pregnancy | 1 | 2018 | 2658 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2011 | 195 | 0.020 |
Why?
| | Egypt | 1 | 2010 | 19 | 0.020 |
Why?
| | Hospitals | 1 | 2010 | 180 | 0.020 |
Why?
| | Genotype | 1 | 2010 | 563 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2010 | 2859 | 0.010 |
Why?
| | Infant | 1 | 2010 | 3660 | 0.010 |
Why?
| | Child | 1 | 2011 | 7147 | 0.010 |
Why?
|
|
Weinkopff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|